» Articles » PMID: 20618951

Safety and Anti-HIV Assessments of Natural Vaginal Cleansing Products in an Established Topical Microbicides in Vitro Testing Algorithm

Abstract

Background: At present, there is no effective vaccine or other approved product for the prevention of sexually transmitted human immunodeficiency virus type 1 (HIV-1) infection. It has been reported that women in resource-poor communities use vaginally applied citrus juices as topical microbicides. These easily accessible food products have historically been applied to prevent pregnancy and sexually transmitted diseases. The aim of this study was to evaluate the efficacy and cytotoxicity of these substances using an established topical microbicide testing algorithm. Freshly squeezed lemon and lime juice and household vinegar were tested in their original state or in pH neutralized form for efficacy and cytotoxicity in the CCR5-tropic cell-free entry and cell-associated transmission assays, CXCR4-tropic entry and fusion assays, and in a human PBMC-based anti-HIV-1 assay. These products were also tested for their effect on viability of cervico-vaginal cell lines, human cervical explant tissues, and beneficial Lactobacillus species.

Results: Natural lime and lemon juice and household vinegar demonstrated anti-HIV-1 activity and cytotoxicity in transformed cell lines. Neutralization of the products reduced both anti-HIV-1 activity and cytotoxicity, resulting in a low therapeutic window for both acidic and neutralized formulations. For the natural juices and vinegar, the IC50 was </= 3.5 (0.8-3.5)% and the TC50 </= 6.3 (1.0-6.3)%. All three liquid products inhibited viability of beneficial Lactobacillus species associated with vaginal health. Comparison of three different toxicity endpoints in the cervical HeLa cell line revealed that all three products affected membrane integrity, cytosolic enzyme release, and dehydrogenase enzyme activity in living cells. The juices and vinegar also exerted strong cytotoxicity in cervico-vaginal cell lines, mainly due to their acidic pH. In human cervical explant tissues, treatment with 5% lemon or lime juice or 6% vinegar induced toxicity similar to application of 100 mug/ml nonoxynol-9, and exposure to 10% lime juice caused tissue damage comparable to treatment with 5% Triton-X-100.

Conclusions: Lemon and lime juice and household vinegar do not fulfill the safety criteria mandated for a topical microbicide. As a result of their unphysiological formulation for the vaginal tract, they exhibit cytotoxicity to human cell lines, human vaginal tissues, and beneficial vaginal Lactobacillus species.

Citing Articles

Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel.

Ekama S, Ilomuanya M, Azubuike C, Ayorinde J, Ezechi O, Igwilo C Gels. 2022; 8(1).

PMID: 35049550 PMC: 8774413. DOI: 10.3390/gels8010015.


Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Rodriguez-Izquierdo I, Sepulveda-Crespo D, Lasso J, Resino S, Munoz-Fernandez M Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14(3):e1774.

PMID: 35018739 PMC: 9285063. DOI: 10.1002/wnan.1774.


Anti-HIV activity of southern African plants: Current developments, phytochemistry and future research.

Prinsloo G, Marokane C, Street R J Ethnopharmacol. 2017; 210:133-155.

PMID: 28807850 PMC: 7125770. DOI: 10.1016/j.jep.2017.08.005.


Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation.

Dezzutti C, Russo J, Wang L, Abebe K, Li J, Friend D PLoS One. 2014; 9(7):e102585.

PMID: 25025306 PMC: 4099179. DOI: 10.1371/journal.pone.0102585.


Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States.

Chen N, Meyer J, Springer S Infect Dis Rep. 2013; 3(1).

PMID: 23745166 PMC: 3671603. DOI: 10.4081/idr.2011.e6.

References
1.
Lard-Whiteford S, Matecka D, ORear J, Yuen I, Litterst C, Reichelderfer P . Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. J Acquir Immune Defic Syndr. 2004; 36(1):541-52. DOI: 10.1097/00126334-200405010-00001. View

2.
Richardson-Harman N, Lackman-Smith C, Fletcher P, Anton P, Bremer J, Dezzutti C . Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. J Clin Microbiol. 2009; 47(11):3530-9. PMC: 2772583. DOI: 10.1128/JCM.00673-09. View

3.
Hillier S, Moench T, Shattock R, Black R, Reichelderfer P, Veronese F . In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr. 2005; 39(1):1-8. DOI: 10.1097/01.qai.0000159671.25950.74. View

4.
Buckheit Jr R, Roberson J, Wyatt J, Vickers T, Ecker D . Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res Hum Retroviruses. 1994; 10(11):1497-506. DOI: 10.1089/aid.1994.10.1497. View

5.
Fichorova R, Rheinwald J, Anderson D . Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod. 1997; 57(4):847-55. DOI: 10.1095/biolreprod57.4.847. View